From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike?
There is a general consensus in re-interpreting the so-called liver function tests in the light of novel discoveries. At the same time, recent evidence favours the use of different laboratory data to assess liver damage, fibrosis or regenerative process, but this point is not always shared. Actually, balancing the need for diagnosis, prognostic evaluation and therapy response of liver disease with a good cost/benefit ratio is very difficult. New tests are probably not needed but the aim should be for better utilization of existing tests to contain the increasing cost of health care.
Tarantino
Giovanni
G
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001291:Attitude of Health Personnel; D015415:Biomarkers / Q000378:metabolism; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis* / Q000201:enzymology / Q000473:pathology; D008111:Liver Function Tests; D011379:Prognosis
D015415:Biomarkers; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase